India Seals Landmark EFTA Deal: Swiss Delights and Global Investment Floodgates Open!

A Pharmaceutical Powerhouse Pivots: Pfizer Embraces Trump's 'Most Favored Nation' Pricing

Game Changer: Pfizer Secures Tariff Reprieve, Vows Lower Drug Prices for Millions of Americans

AbbVie Unleashes Future Growth: $70 Million R&D and Manufacturing Hub Breaks Ground in Singapore

TrumpRx Unleashes Massive 85% Discounts on Pfizer Drugs: A Game Changer?

The "TrumpRx" Initiative: A Disruptive Force in the Pharmaceutical Landscape, Challenging Giants Like Pfizer

MoonLake Therapeutics (MLTX) Shares Surge: A Deep Dive into Its Resilience Amidst Analyst Skepticism

Trump Hails Landmark Pfizer Deal: $70 Million US Investment and Drug Price Cuts Announced

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

Trump Hails "Historic" Deal with Pfizer to Drastically Cut Drug Prices

Trump's Bold Move: White House Pressures Pharma Giants for Lower Drug Prices

AstraZeneca's American Dream: Why a US Listing Could Unlock a 20% Value Surge

IPG Secures Staggering $720 Million Global Media Mandate for Bayer Consumer Health

AI Agents Unleashed: Revolutionizing Healthcare and Life Sciences as We Know It

Aurinia Pharma Stands Firm: Lupus Drug Lupkynis Defies FDA Post-Scandal Amidst Market Jolt

Unveiling the Shadowy Ethics: Former Pharma CEO's FDA Claims Spark Regulatory Outcry

AnaptysBio Unleashes Dual Powerhouse: Splitting into Dedicated Immunology and Oncology Ventures

A New Dawn for Pain Relief: Cannabis-Derived Drug Offers Hope to Millions

Lupin's Visionary Move: Eyeing European Domination with VisuFarma Acquisition

Biotech Blockbuster Alert: Genmab Edges Closer to Game-Changing Merus Acquisition

Trade Triumphs: How EU and Japan Navigated Trump's Pharmaceutical Tariff Storm

Johnson & Johnson's Unwavering Commitment to Innovation: A Glimpse into the Future of Healthcare

Pharma's Unseen Shift: Citi's Meacham Reveals Deep-Rooted U.S. Investment Promises Already Underway

Market Crossroads: TikTok's Profit Power, Accenture's AI Dilemma, and the Looming Drug Tariff Battle

Alkermes Skyrockets as RBC Capital Markets Unlocks Lybalvi's Blockbuster Potential

Apellis Pharmaceuticals Faces Investor Jitters as Goldman Sachs Issues "Sell" Rating on Escalating Competitive Threats

AstraZeneca's Bold Leap: Transforming Patient Access with New Direct-to-Consumer Platform

Harrow's Strategic Move: Acquiring Melt Pharmaceuticals to Redefine Sedation Solutions

India's Measured Response: MEA Closely Monitoring Trump's 100% Pharma Tariff Talk

Trump's Bold Pharmaceutical Tariff: A 100% Game Changer?

Trump's Bold New Tariffs: Reshaping the Pharmaceutical and Furniture Industries

Trump's Bold Pharma Tariff Move: Will India Feel the Pinch?

A Breath of Relief: How Trump's Drug Tariffs Spare India's Generic Pharma Giants

Trump's Tariff Tango: India's Exports in the Crosshairs

Trump Unleashes 100% Tariff on Imported Branded Drugs, Shaking Up Global Pharma

AstraZeneca Unleashes Legal Barrage Against Medicare Drug Price Controls

FDA Lifts Restrictions: A New Chapter for Sanofi's Caprelsa in Thyroid Cancer Treatment

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

Tiziana Life Sciences Soars: Beyond Foralumab, a Second Asset Ignites Investor Excitement and Future Potential